![Adele Gulfo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 2 M $ au 31/05/2026
Ms. Adele M.
Gulfo is an Independent Non-Executive Director at NewAmsterdam Pharma Co. NV, an Independent Director at Tyra Biosciences, Inc., an Independent Director at Enpro, Inc., a Board of Advisor at 1843 Capital LLC and a Member-Innovation Growth Board at Mass General Brigham, Inc. She is on the Board of Directors at NewAmsterdam Pharma Co. NV, Tyra Biosciences, Inc. and Enpro, Inc. Ms. Gulfo was previously employed as a Chief Executive Officer-Biopharma Commercial Unit by Sumitomo Pharma America, Inc., a Chief Business & Commercial Development Officer by Sumitovant Biopharma, Inc., an Independent Director by Medexus Pharmaceuticals, Inc., a Chief Commercial Development Officer by Roivant Sciences Ltd., an Independent Director by Bemis Co., Inc., an EVP-Global Collaboration & Strategic Operations by Mylan, Inc., an Executive VP & Head-Global Commercial Development by Mylan NV, a President & General Manager by Pfizer Inc., and a Vice President by AstraZeneca PLC.
She also served on the board at Myovant Sciences Ltd., The Committee of 200 and Volunteers of America, Inc. She received her undergraduate degree from Seton Hall University, a graduate degree from the University of Medicine & Dentistry of New Jersey and an MBA from Fairleigh Dickinson University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ENPRO INC. 0,02 % | 17/06/2026 | 4 860 ( 0,02 % ) | 1 M $ | 31/05/2026 |
TYRA BIOSCIENCE, INC 0,01 % | 28/05/2026 | 4 000 ( 0,01 % ) | 133 640 $ | 31/05/2026 |
| 15/04/2026 | 3 620 ( 0 % ) | 121 922 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ENPRO INC. | Directeur/Membre du Conseil | 30/10/2018 |
| TYRA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 29/01/2025 |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Directeur/Membre du Conseil | 15/04/2025 |
1843 Capital LLC
 1843 Capital LLC Investment ManagersFinance 1843 Capital invests in companies located in the United States. The firm targets companies operating in the fields of health, wellness, mobility, fintech, cyber security and technology services. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Mass General Brigham, Inc.
 Mass General Brigham, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit integrated healthcare system | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | 30/09/2024 |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets drugs | Corporate Officer/Principal | 01/09/2024 |
| MYOVANT SCIENCES LTD. | Directeur/Membre du Conseil | 01/06/2021 |
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01/12/2019 |
| ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 20 |
|---|---|
Bemis Co., Inc.
 Bemis Co., Inc. Containers/PackagingProcess Industries Manufactures industrial and consumer packaging products | Process Industries |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Enpro, Inc.
 Enpro, Inc. Industrial MachineryProducer Manufacturing Manufactures and sells gaskets, sealing products, optical filters, thin film coatings & wafer processing sub-systems | Producer Manufacturing |
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Mylan NV
 Mylan NV Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
University of Medicine & Dentistry of New Jersey
 University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Volunteers of America, Inc.
 Volunteers of America, Inc. Services to the Health IndustryHealth Services Provides housing and health care services | Health Services |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
 Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mass General Brigham, Inc.
Mass General Brigham, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit integrated healthcare system | Commercial Services |
The Committee of 200
 The Committee of 200 Miscellaneous Commercial ServicesCommercial Services Operates membership organization of the women entrepreneurs and corporate innovators | Commercial Services |
Medexus Pharmaceuticals, Inc.
 Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital invests in companies located in the United States. The firm targets companies operating in the fields of health, wellness, mobility, fintech, cyber security and technology services. It provides financing for early stage capital requirements. | Finance |
Tyra Biosciences, Inc.
 Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets drugs | Health Technology |
NewAmsterdam Pharma Co. NV
 NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
